Lihuai Wang
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction: Development and clinical validation of a nursing risk prediction model for chemotherapy-induced febrile neutropenia in patients with cancer.
Journal: Frontiers in cell and developmental biology
Published: June 01, 2026
Development and clinical validation of a nursing risk prediction model for chemotherapy-induced febrile neutropenia in patients with cancer.
Journal: Frontiers in cell and developmental biology
Published: January 02, 2026
Metabolic reprogramming and lung cancer focused on roles, mechanism, and clinical prospects of circRNAs: a narrative review.
Journal: Frontiers in oncology
Published: November 02, 2025
A Novel Strategy for Enhancing Lung Cancer Immunotherapy Efficacy: Traditional Chinese Medicine Formula Shuyu Pills Enhances Anti-PD-1 Efficacy Via the "GM-ERS-Immunity" Axis.
Journal: Biological procedures online
Published: August 11, 2025
Centipede Polypeptide Affects the Inflammatory Reaction and Ferroptosis of Liver Cancer Cells Through the p53/TRAIL Pathway.
Journal: Journal of cellular and molecular medicine
Published: May 21, 2025
Clinical Retrospective Study on the Role of Spleen-Invigorating and Qi-Supporting Therapy in Non-Small Cell Lung Cancer Immunotherapy and Construction of Survival Prediction Model.
Journal: Biological procedures online
Published: May 18, 2025
Dysregulation of gut microbiota stimulates NETs-driven HCC intrahepatic metastasis: therapeutic implications of healthy faecal microbiota transplantation.
Journal: Gut microbes
Published: March 18, 2025
"Molecular pigeon" network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer.
Journal: Frontiers in oncology
Published: February 18, 2025
Astragaloside IV Overcomes Anlotinib Resistance in Non-small Cell Lung Cancer through miR-181a-3p/UPR-ERAD Axis.
Journal: Current computer-aided drug design
Published: May 18, 2023
Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways.
Journal: Open medicine (Warsaw, Poland)
Published: April 06, 2023
COL3A1 Overexpression Associates with Poor Prognosis and Cisplatin Resistance in Lung Cancer
Journal: Balkan medical journal
Published: September 23, 2022
Last Updated: 09/26/2026